Ruijin Hospital
Clinical trials sponsored by Ruijin Hospital, explained in plain language.
-
New drug shows promise in reducing clot risk for rare autoimmune disease
Disease control CompletedThis study tested a drug called telitacicept in 20 adults with antiphospholipid syndrome (APS), a condition where the immune system mistakenly attacks healthy cells, raising the risk of blood clots. The goal was to see if the drug could lower levels of harmful antibodies linked t…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Brain zaps + arm drills: new combo therapy shows promise for stroke recovery
Symptom relief CompletedThis study tested whether combining a non-invasive brain stimulation technique (rTMS) with arm motor training helps stroke survivors regain upper limb function. Sixty adults who had a stroke and had arm weakness were randomly assigned to receive either online rTMS (during trainin…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC
-
New imaging method could help ventilators cause less lung damage
Knowledge-focused CompletedThis study tested a new way to monitor lung function in 120 critically ill patients with ARDS (a severe lung condition). Researchers used electrical impedance tomography (EIT), a non-invasive imaging tool, to see how different ventilator pressure levels affected lung opening and …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
New breathing tube technique may simplify lung nodule removal
Knowledge-focused CompletedThis study looked at 375 patients having surgery to remove small lung nodules. Doctors tested a simpler method using one breathing tube instead of switching to a different tube during the procedure. The goal was to see if the simpler method is just as safe and effective.
Phase: NA • Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC